Biocides

The Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) concerns the placing on the market and use of biocidal products, which are used to protect humans, animals, materials or articles against harmful organisms like pests or bacteria, by the action of the active substances contained in the biocidal product. This regulation aims to improve the functioning of the biocidal products market in the EU, while ensuring a high level of protection for humans and the environment. All biocidal products require an authorisation before they can be placed on the market, and the active substances contained in that biocidal product must be previously approved.

The BPR aims to harmonise the market at Union level; simplify the approval of active substances and authorisation of biocidal products.

Do you sometimes feel overpowered?

ARCHE Consulting is constantly shifting the goalposts within the biocidal regulatory arena to create a level playing field for its clients. Choose your preferred option here below.

Biocidal product family

  • Group products
  • Flexible to add products later
  • Provides additional support to your customers

Joint dossier preparation

  • Prepare joint product family dossier
  • Opportunity for data sharing at a larger scale

Consortia for biocides *

  • Gives SME’s the opportunity to stay on the market at low costs

(*) Arche offers a one-stop for preparing biocidal product family dossiers in a consortium. This can significantly reduce the costs for dossier preparation and fees to ECHA and the evaluating Competent Authority. Cost Reduction: More than 50% cost savings possible!

How can we safeguard your market?

Arche offers a wide range of services from tailor-made strategic advice to training modules. Don’t hesitate to contact us for a competitive offer suited for your company.

  • Data gap analysis, coordination of tests, waivers
  • Risk assessment (human health, environment)
  • Active substance dossier and Article 95 inclusion, TE
  • Biocidal products: single product and product family dossiers
  • Pre-submission meetings with ECHA and evaluating CA
  • National Authorizations, Mutual Recognitions, Union Authorisation
  • Consortia for biocides
  • IUCLID & R4BP3

Risk assessment, IUCLID,…